Free shipping on US orders over $300

For Research Use Only. Not For Human Consumption

Larazotide 500mcg (60 Capsules)

Larazotide 500mcg 60 capsules research compound bottle RawBiotix

Larazotide 500mcg (60 Capsules)

A synthetic octapeptide supplied in oral research format, 60 capsules at 500mcg. Studied in zonulin antagonism, tight junction regulation, and intestinal epithelial barrier permeability models. Supplied for in vitro research by qualified laboratory personnel.

Price range: $89.99 through $749.99

Free shipping on US orders over $300

Disclaimer: For laboratory research use only. Not for human consumption, therapeutic, or diagnostic purposes.

Product Usage: For Research Use Only – Not for Human or Veterinary Use

This product is not a drug, food, cosmetic, or dietary supplement and has not been reviewed or approved by the FDA. It is intended strictly for in vitro research conducted by qualified professionals. Use in humans or animals is not permitted and may be subject to federal, state, or local regulations, including the Federal Food, Drug, and Cosmetic Act. No therapeutic or diagnostic use is implied or authorized. The purchaser is solely responsible for ensuring compliance with all applicable laws and regulations. By completing a purchase, the buyer confirms that this product will be used exclusively for in vitro research purposes and acknowledges that RawBiotix maintains internal policies designed to support research-use-only sales.

Description

Overview Larazotide acetate is a research-grade synthetic octapeptide supplied in oral research format for controlled laboratory use. It is intended for in vitro and analytical work examining zonulin antagonism, tight junction regulation, and intestinal epithelial barrier permeability models.

Research Background & Mechanistic Focus Current research use centers on zonulin-mediated tight junction modulation, paracellular transport regulation, and occludin-claudin protein complex interaction in intestinal epithelial models. Larazotide has been examined in celiac disease, IBS-D, and barrier dysfunction experimental systems, with a documented published record across multiple clinical-phase and preclinical investigations. A fuller reference summary of the compound, its sequence and the mechanism under investigation is available in the Larazotide research overview.

Structural Information Classification: Synthetic octapeptide, zonulin antagonist. Sequence: Gly-Gly-Val-Leu-Val-Gln-Pro-Gly. CAS number: 881851-50-9. Molecular formula: C32H55N9O10. Molecular weight: 725.8 Da. Form: Oral research format, 60 capsules. Catalog Strength: 500mcg.

Research Applications Used in controlled laboratory settings for intestinal barrier integrity models, tight junction protein studies, paracellular permeability analysis, and zonulin pathway research.

Specifications Research-grade material supplied in oral research presentation at selected catalog variants. Intended for controlled laboratory handling and analytical preparation only.

Handling & Use Conditions Handle sealed oral research format units with standard laboratory PPE. Keep the container tightly closed between uses and protect the material from heat, moisture, and cross-contamination during laboratory handling.

Storage & Stability Store in a cool, dry environment away from heat, moisture, and direct light. Keep the container sealed when not in use to support material stability during the study period.

Sourcing Statement RawBiotix research compounds are sourced through U.S.-based supply and verified through independent analytical testing. Minimum 98% purity. Certificates of Analysis available upon request.

Disclaimer For laboratory research use only. Not for human consumption, therapeutic, or diagnostic purposes.

Additional information

Quantity

Q1, Q3, Q5, Q10

Reviews

There are no reviews yet.

Be the first to review “Larazotide 500mcg (60 Capsules)”

Your email address will not be published. Required fields are marked *

Research Compounds

Related Products

Search Research Compounds